The use of non-viral vectors for in vivo gene therapy could drastically increase safety, whilst reducing the cost of preparing the vectors. A promising approach to non-viral vectors makes use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback